Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jul;12(7):1125-1127.
doi: 10.1111/jdi.13605.

The COVID-19 world - Are we there yet?

Yoshiyuki Hamamoto  1   2
Affiliations
Editorial

The COVID-19 world - Are we there yet?

Yoshiyuki Hamamoto. J Diabetes Investig. 2021 Jul.

Abstract

The spreading of SARS-CoV-2 virus infection is still of great concern as well as clinical and social interest. The key to conquer this pandemic would be establishment of herd immunity by vaccination and of treatment, and I have discussed issues we are facing now.

PubMed Disclaimer

Conflict of interest statement

Y Hamamoto received speaker fees from Novo Nordisk Pharma Ltd and received a research grant from Sumitomo‐Dainippon Pharma Co., Ltd and Nippon Boehringer Ingelheim.

Figures

Figure 1|
Figure 1|
The schematic illustration of the problems and tasks that need to be solved, verified, and validated to conquer COVID‐19 and related issues in diabetes.
See this image and copyright information in PMC

References

    1. Tanaka N, Hamamoto Y, Kurotobi Y, et al. Lifestyle changes as a result of COVID‐19 containment measures: bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency. J Diabetes Investig 2021. 10.1111/jdi.13526. - DOI - PMC - PubMed
    1. Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid‐19 vaccine in a nationwide mass vaccination setting. N Engl J Med 2021; 384: 1412–1423. - PMC - PubMed
    1. Wang Z, Schmidt F, Weisblum Y, et al. mRNA vaccine‐elicited antibodies to SARS‐CoV‐2 and circulating variants. Nature 2021; 592: 616–622. - PMC - PubMed
    1. Hata A, Inoue F, Hamamoto Y, et al. Efficacy and safety of live varicella vaccine in diabetes patients: a randomized, double‐blind, placebo‐controlled, clinical trial. Diabet Med 2016; 33: 1094–1101. - PubMed
    1. RECOVERY Collaborative Group . Tocilizumab in patients admitted to hospital with COVID‐19 (RECOVERY): a randomised, controlled, open‐label, platform trial. Lancet 2021; 397: 1637–1645. - PMC - PubMed

Publication types

Substances